2252 Stock Overview
Shanghai MicroPort MedBot (Group) Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shanghai MicroPort MedBot (Group) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$10.16 |
| 52 Week High | HK$21.35 |
| 52 Week Low | HK$6.03 |
| Beta | 1.2 |
| 1 Month Change | 5.18% |
| 3 Month Change | 41.11% |
| 1 Year Change | -45.67% |
| 3 Year Change | -83.97% |
| 5 Year Change | n/a |
| Change since IPO | -77.82% |
Recent News & Updates
Recent updates
Why We're Not Concerned About Shanghai MicroPort MedBot (Group) Co., Ltd.'s (HKG:2252) Share Price
Aug 30
Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Analysts Just Trimmed Their Revenue Forecasts By 58%
Apr 12Is Shanghai MicroPort MedBot (Group) (HKG:2252) Using Debt Sensibly?
Mar 29Is Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 24We're Not Very Worried About Shanghai MicroPort MedBot (Group)'s (HKG:2252) Cash Burn Rate
May 19Here's Why We're Not Too Worried About Shanghai MicroPort MedBot (Group)'s (HKG:2252) Cash Burn Situation
Feb 02Shareholder Returns
| 2252 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -8.5% | -3.8% | -2.2% |
| 1Y | -45.7% | -28.7% | 18.3% |
Return vs Industry: 2252 underperformed the Hong Kong Medical Equipment industry which returned -28.7% over the past year.
Return vs Market: 2252 underperformed the Hong Kong Market which returned 18.3% over the past year.
Price Volatility
| 2252 volatility | |
|---|---|
| 2252 Average Weekly Movement | 20.2% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.7% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 2252's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2252's weekly volatility has increased from 14% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 560 | Chao He | www.medbotsurgical.com |
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR’obot, a Mona Lisa robotic transperineal prostate biopsy system.
Shanghai MicroPort MedBot (Group) Co., Ltd. Fundamentals Summary
| 2252 fundamental statistics | |
|---|---|
| Market cap | HK$9.87b |
| Earnings (TTM) | -HK$798.98m |
| Revenue (TTM) | HK$166.36m |
59.3x
P/S Ratio-12.4x
P/E RatioIs 2252 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2252 income statement (TTM) | |
|---|---|
| Revenue | CN¥156.23m |
| Cost of Revenue | CN¥116.59m |
| Gross Profit | CN¥39.64m |
| Other Expenses | CN¥789.96m |
| Earnings | -CN¥750.32m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.77 |
| Gross Margin | 25.37% |
| Net Profit Margin | -480.28% |
| Debt/Equity Ratio | 167.8% |
How did 2252 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 00:50 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai MicroPort MedBot (Group) Co., Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Muk Tsz Yung | Citigroup Inc |
| Eva Zhao | Citigroup Inc |
| Dennis Ip | Daiwa Securities Co. Ltd. |